“Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients ”. Journal of Cancer Research Updates 1, no. 1 (January 28, 2012):  44–48. Accessed May 2, 2026. https://www.neoplasiaresearch.com/index.php/jcru/article/view/372.